InsidersTradesSigma
Browse the full management transaction log of Senores Pharmaceuticals, a listed equity based in India. Shares trade on IN IN, under the oversight of SEBI (PIT + SAST). Market capitalisation: €57.2bn. The latest transaction was disclosed on 25 May 2026 (Acquisition). Among the most active insiders: Swapnil Jatin Shah & Others. Every trade is free.
Analysts rate Senores Pharmaceuticals Strong Buy (bullish), based on 4 analysts. Average price target: ₹1,174.25.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal. See the method
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
1 of 1 declaration